A Phase 1 Subject-Blinded, Placebo-Controlled Dose Escalation and Repeat Dose Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Healthy Subjects
100 Clinical Results associated with Delpharm Consultants Pty Ltd.
0 Patents (Medical) associated with Delpharm Consultants Pty Ltd.
100 Deals associated with Delpharm Consultants Pty Ltd.
100 Translational Medicine associated with Delpharm Consultants Pty Ltd.